DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Cho BC, Dy GK, Govindan R. et al.
Phase Ib/II study of the pan-cyclin-dependent kinase inhibitor roniciclib in combination with chemotherapy in patients with extensive-disease small-cell lung cancer.
Lung Cancer 2018;
123: 14-21
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.